Related references
Note: Only part of the references are listed.Factors associated with the prescription of traditional'' or biological'' systemic treatment in psoriasis
Stefano Tabolli et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
Treatment patterns with topicals, traditional systemics and biologics in psoriasis - a Swedish database analysis
A. Svedbom et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry
Stefano Piaserico et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Cost Effectiveness of Biologic Therapies for Plaque Psoriasis
Christine S. Ahn et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2013)
Dose escalation may be effective in patients with psoriasis after treatment failure or suboptimal response, but switching to adalimumab is the most cost-effective measure in different scenarios
L. Puig
BRITISH JOURNAL OF DERMATOLOGY (2013)
Survival rate of antitumour necrosis factor- treatments for psoriasis in routine dermatological practice: a multicentre observational study
M. Esposito et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Field Performance of the Skindex-17 Quality of Life Questionnaire: A Comparison with the Skindex-29 in a Large Sample of Dermatological Outpatients
Francesca Sampogna et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social Life
Francesca Sampogna et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
R. Gniadecki et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis
Lidian L. A. Lecluse et al.
ARCHIVES OF DERMATOLOGY (2010)
Switching biologics for psoriasis
Anthony D. Ormerod
BRITISH JOURNAL OF DERMATOLOGY (2010)
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: Preliminary data
Eleonora Annichiarico et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Testing and reducing Skindex-29 using Rasch analysis: Skindex-17
Tamar E. C. Nijsten et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Measuring quality of life of patients with different clinical types of psoriasis using the SF-36
F Sampogna et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Share Paper
